In RA patients treated with bDMARDs, the number of CD14-positive cells (×105) in the IFP was 1.89 (0.69–2.49); however, this number decreased to 0.39 (0.13–1.74) in the SC. Here, CD14 is linked to rheumatoid arthritis.